In a 12‑year‑old male with ADHD on methylphenidate 30 mg each morning, aripiprazole 7.5 mg at bedtime, and sertraline 100 mg daily (planned increase to 150 mg), are the eye‑blinking episodes stress‑related and should the stimulant be changed?

Do Not Change the Stimulant – The Eye Blinking Has Already Resolved

You should continue methylphenidate 30 mg as currently prescribed because the eye blinking and neck jerking have completely resolved (AIMS = 0), and there is no current evidence of tics. The previous transient motor movements were likely stress-related and have spontaneously remitted without any medication changes 1.

Key Clinical Reasoning

The Tics Have Already Disappeared

• Your patient's repeat AIMS score is 0
• He explicitly denies any current blinking or neck jerks
• The movements resolved while he remained on the same methylphenidate dose
• This temporal pattern strongly suggests the movements were transient stress-related phenomena rather than stimulant-induced tics

Evidence Supports Continuing Stimulants Even With Comorbid Tics

Multiple double-blind placebo-controlled studies demonstrate that stimulants are highly effective in ADHD patients with comorbid tic disorders, and in the majority of patients, tics do not increase 1. The guideline explicitly states: "With proper informed consent, a trial of a stimulant could be undertaken in children with comorbid ADHD and tic disorder. If tics do not increase and the ADHD symptoms respond, however, then the child may remain on the stimulant" 1.

When to Actually Change Stimulants

You would only switch stimulants if: "tics worsen markedly" 1. This has not occurred. In fact, the opposite happened—the movements disappeared.

The guideline framework is clear:

1. Continue stimulant if tics remain stable or improve (your situation)
2. Switch to alternative stimulant only if tics worsen markedly
3. If tics remain problematic despite good ADHD response, add alpha-agonists like clonidine or guanfacine rather than discontinuing the effective stimulant 1

Address the Real Clinical Issue: Anxiety

Your actual treatment target should be the situational anxiety, not the resolved motor movements. The patient has:

• Increased situational anxiety with class changes, crowded hallways, social stress
• One recent episode of coming home "all stressed out"
• Chronic skin-picking (anxiety-related body-focused repetitive behavior)

Your plan to increase sertraline from 100 mg to 150 mg daily is appropriate 2. The FDA label supports doses up to 200 mg/day for anxiety disorders in this age group, with dose increases at intervals of at least 1 week 2. Moving sertraline to morning dosing may also help with daytime anxiety coverage.

Comorbid Anxiety and ADHD: Evidence Base

Stimulants remain effective and appropriate first-line treatment even with comorbid anxiety 1. Early concerns that ADHD children with comorbid anxiety had less robust stimulant response were not replicated in larger trials including the MTA study 1. The guideline states: "Thus, the clinician should proceed with a stimulant trial. If the stimulant improves the ADHD symptoms but the anxiety symptoms remain problematic, the clinician may pursue a psychosocial intervention for the anxiety. If the anxiety does not respond to nonpharmacological treatment or is severe, the clinician may consider adding an SSRI to the stimulant" 1.

You are already doing exactly what the evidence recommends: continuing the effective stimulant while optimizing SSRI treatment for residual anxiety.

Common Pitfalls to Avoid

Do not conflate transient stress-related movements with stimulant-induced tics. The temporal resolution of symptoms without medication change is your key diagnostic clue. Prematurely switching from an effective stimulant based on resolved symptoms would be inappropriate and could destabilize his ADHD control.

Do not attribute every motor phenomenon to medication. Children experience transient motor behaviors for many reasons—stress, anxiety, habit, developmental variation. The fact that these resolved spontaneously while on stable medication argues against a causal relationship.

Monitoring Plan

Continue current regimen with:

• Methylphenidate 30 mg AM (unchanged)
• Aripiprazole 7.5 mg qHS (unchanged)
• Sertraline increased to 150 mg daily, moved to morning dosing
• Monitor for any recurrence of motor movements at follow-up
• Assess anxiety response to increased sertraline dose
• Address skin-picking behavior as anxiety-related phenomenon requiring behavioral intervention

If motor tics were to re-emerge and worsen markedly in the future, only then would you consider switching to an alternative stimulant or adding an alpha-2 agonist 1. But that is not your current clinical scenario.